Vuno Inc. Stock price

Equities

A338220

KR7338220007

IT Services & Consulting

End-of-day quote Korea S.E. 07:00:00 2024-03-26 pm EDT 5-day change 1st Jan Change
31,950 KRW -3.03% Intraday chart for Vuno Inc. -0.93% -23.93%
Sales 2024 * 28.3B 20.94M Sales 2025 * 36.85B 27.27M Capitalization 437B 324M
Net income 2024 * -4B -2.96M Net income 2025 * -2B -1.48M EV / Sales 2024 * 15.3 x
Net cash position 2024 * 5.4B 4M Net cash position 2025 * 13.7B 10.14M EV / Sales 2025 * 11.5 x
P/E ratio 2024 *
-98.9 x
P/E ratio 2025 *
-205 x
Employees 142
Yield 2024 *
-
Yield 2025 *
-
Free-Float 85.63%
More Fundamentals * Assessed data
Dynamic Chart
1 day-3.03%
1 week-0.93%
Current month+7.94%
1 month+5.62%
3 months-25.44%
6 months-18.18%
Current year-23.93%
More quotes
1 week
31 300.00
Extreme 31300
36 450.00
1 month
28 400.00
Extreme 28400
36 450.00
Current year
26 350.00
Extreme 26350
41 850.00
1 year
14 240.00
Extreme 14240
69 500.00
3 years
5 000.00
Extreme 5000
69 500.00
5 years
5 000.00
Extreme 5000
69 500.00
10 years
5 000.00
Extreme 5000
69 500.00
More quotes
Managers TitleAgeSince
Founder 43 14-12-09
Founder 47 14-12-09
Founder 46 14-12-09
Members of the board TitleAgeSince
Director/Board Member 45 -
Director of Finance/CFO 44 20-03-31
Director/Board Member 49 -
More insiders
Date Price Change Volume
24-03-27 31,950 -3.03% 355,613
24-03-26 32,950 -5.04% 374,748
24-03-25 34,700 -1.28% 266,914
24-03-22 35,150 +2.78% 585,069
24-03-21 34,200 +6.05% 324,461

End-of-day quote Korea S.E., March 26, 2024

More quotes
Vuno Inc is a Korea-based company primarily engaged in the development of medical diagnostic, predictive technologies and solutions based on artificial intelligence (AI) technology.The Company develops and manufactures medical imaging products that assist with medical image-based diagnosis such as X-ray, computed tomography (CT), magnetic resonance imaging (MRI), and funduscopy; pathology products that assist in the detection of digital scanners, microscopy-based cell quantification and tumor cells; biosignal products that assist and predict diagnosis based on time-series biosignal data such as vital signs and electrocardiogram; medical voice products that automatically create medical charts based on voice recognition. In addition, the Company sells an embolic material product, Nexpear. The Company sells its products in domestic and overseas markets such as Japan, Europe, and the United States.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
31,950 KRW
Average target price
45,000 KRW
Spread / Average Target
+40.85%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Vuno Inc. - Korea S.E.